Vertex Resource Group Ltd. ("Vertex" or the "Company") reports its financial and operational results for the third quarter ...

Vertex Pharmaceuticals recently presented updated interim data at the 2025 ASN Kidney Week, revealing significant proteinuria ...

V2X, Inc. (NYSE:VVX) ("V2X"), a leading provider of global mission solutions, announced today the sale of 2.25 million shares ...

Vertex Minerals Ltd. reported that the stripping of areas of low back height has been completed, and rehabilitation of Decline 3 is progressing well with approximately 100m of decline to be bolted ...

Positive Phase 1 data for CTX310® presented in a late-breaking presentation at the American Heart Association (AHA) ...

CAMBRIDGE, Mass., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company focused on developing transformative medicines for serious diseases, today ...

Tech stocks and top consumer names are increasingly at risk of steep declines in a slowing economy. Click here to see 5 ...

SEP-479 Selected as Next-Generation Oral PTH1R Agonist Development Candidate SEP-631 (MRGPRX2 NAM) Phase 1 Clinical Trial in Healthy Volunteers Ongoing Robust Financial Position of $561.6 Million ...

Nektar Therapeutics today presented new data from the ongoing REZOLVE-AD Phase 2b study in a late-breaking oral abstract presentation at the American College of Allergy, Asthma & Immunology (ACAAI) ...

Odyssey Math Tuition launches a Secondary 2 online math tuition elearning course in Singapore, featuring a proprietary ...

Focused U.S. Small Cap Active ETF gained (gross of fees) but underperformed the Russell 2000 Index. Read more here.